ID   FAS_HUMAN               Reviewed;        2511 AA.
AC   P49327; Q13479; Q16702; Q4LE83; Q6P4U5; Q6SS02; Q969R1; Q96C68;
AC   Q96IT0;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   10-MAY-2017, entry version 194.
DE   RecName: Full=Fatty acid synthase;
DE            EC=2.3.1.85;
DE   Includes:
DE     RecName: Full=[Acyl-carrier-protein] S-acetyltransferase;
DE              EC=2.3.1.38;
DE   Includes:
DE     RecName: Full=[Acyl-carrier-protein] S-malonyltransferase;
DE              EC=2.3.1.39;
DE   Includes:
DE     RecName: Full=3-oxoacyl-[acyl-carrier-protein] synthase;
DE              EC=2.3.1.41;
DE   Includes:
DE     RecName: Full=3-oxoacyl-[acyl-carrier-protein] reductase;
DE              EC=1.1.1.100;
DE   Includes:
DE     RecName: Full=3-hydroxyacyl-[acyl-carrier-protein] dehydratase;
DE              EC=4.2.1.59;
DE   Includes:
DE     RecName: Full=Enoyl-[acyl-carrier-protein] reductase;
DE              EC=1.3.1.39;
DE   Includes:
DE     RecName: Full=Oleoyl-[acyl-carrier-protein] hydrolase;
DE              EC=3.1.2.14;
GN   Name=FASN; Synonyms=FAS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY,
RP   PHOSPHOPANTETHEINYLATION AT SER-2156, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7567999; DOI=10.1073/pnas.92.19.8695;
RA   Jayakumar A., Tai M.-H., Huang W.-Y., Al-Feel W., Hsu M.,
RA   Abu-Elheiga L., Chirala S.S., Wakil S.J.;
RT   "Human fatty acid synthase: properties and molecular cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8695-8699(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hennigar R.A., Jenner K.H., Heine H.S., Kayler A.E., Wood F.D.,
RA   Kuhajda F.P., Pasternack G.R.;
RT   "Molecular cloning of tumor-associated human fatty acid synthase.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Mao J., Wakil S.J.;
RT   "Recharacterization of the human fatty acid synthase (FAS) gene.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-12; 647-666; 791-802; 1242-1255; 1338-1349 AND
RP   2126-2138, ACETYLATION AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (JUL-2005) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 753-758 AND 1285-1297.
RX   PubMed=8022791; DOI=10.1073/pnas.91.14.6379;
RA   Kuhajda F.P., Jenner K., Wood F.D., Hennigar R.A., Jacobs L.B.,
RA   Dick J.D., Pasternack G.R.;
RT   "Fatty acid synthesis: a potential selective target for antineoplastic
RT   therapy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6379-6383(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2047-2511, AND TISSUE SPECIFICITY.
RX   PubMed=7595075;
RA   Semenkovich C.F., Coleman T., Fiedorek F.T. Jr.;
RT   "Human fatty acid synthase mRNA: tissue distribution, genetic mapping,
RT   and kinetics of decay after glucose deprivation.";
RL   J. Lipid Res. 36:1507-1521(1995).
RN   [10]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2198 AND THR-2204, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-2198; THR-2204
RP   AND SER-2236, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2204, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70; LYS-298; LYS-436;
RP   LYS-528; LYS-673; LYS-1704; LYS-1771; LYS-1847 AND LYS-1995, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-207; SER-1411;
RP   SER-1584; SER-2198; THR-2204 AND THR-2215, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1174; SER-1411;
RP   SER-2198; THR-2204 AND THR-2215, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2449, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   3D-STRUCTURE MODELING, AND STRUCTURE BY ELECTRON CRYOMICROSCOPY.
RX   PubMed=11756679; DOI=10.1073/pnas.012589499;
RA   Brink J., Ludtke S.J., Yang C.Y., Gu Z.-W., Wakil S.J., Chiu W.;
RT   "Quaternary structure of human fatty acid synthase by electron
RT   cryomicroscopy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:138-143(2002).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2218-2502.
RX   PubMed=15507492; DOI=10.1073/pnas.0406901101;
RA   Chakravarty B., Gu Z., Chirala S.S., Wakil S.J., Quiocho F.A.;
RT   "Human fatty acid synthase: structure and substrate selectivity of the
RT   thioesterase domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15567-15572(2004).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 2119-2207 IN COMPLEX WITH
RP   AASDHPPT AND COENZYME A.
RX   PubMed=18022563; DOI=10.1016/j.chembiol.2007.10.013;
RA   Bunkoczi G., Pasta S., Joshi A., Wu X., Kavanagh K.L., Smith S.,
RA   Oppermann U.;
RT   "Mechanism and substrate recognition of human holo ACP synthase.";
RL   Chem. Biol. 14:1243-1253(2007).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 2200-2511 IN COMPLEX WITH
RP   ORLISTAT, AND ACTIVE SITE FOR THIOESTERASE ACTIVITY.
RX   PubMed=17618296; DOI=10.1038/nsmb1265;
RA   Pemble C.W. IV, Johnson L.C., Kridel S.J., Lowther W.T.;
RT   "Crystal structure of the thioesterase domain of human fatty acid
RT   synthase inhibited by Orlistat.";
RL   Nat. Struct. Mol. Biol. 14:704-709(2007).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 422-831 IN COMPLEX WITH
RP   MALONYL-COENZYME A.
RG   Structural genomics consortium (SGC);
RT   "Structure of the MAT domain of human FAS with malonyl-CoA.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Fatty acid synthetase catalyzes the formation of long-
CC       chain fatty acids from acetyl-CoA, malonyl-CoA and NADPH. This
CC       multifunctional protein has 7 catalytic activities and an acyl
CC       carrier protein.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + n malonyl-CoA + 2n NADPH = a
CC       long-chain fatty acid + (n+1) CoA + n CO(2) + 2n NADP(+).
CC       {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [acyl-carrier-protein] = CoA +
CC       acetyl-[acyl-carrier-protein]. {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: Malonyl-CoA + an [acyl-carrier-protein] = CoA
CC       + a malonyl-[acyl-carrier-protein]. {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: Acyl-[acyl-carrier-protein] + malonyl-[acyl-
CC       carrier-protein] = 3-oxoacyl-[acyl-carrier-protein] + CO(2) +
CC       [acyl-carrier-protein]. {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: (3R)-3-hydroxyacyl-[acyl-carrier-protein] +
CC       NADP(+) = 3-oxoacyl-[acyl-carrier-protein] + NADPH.
CC       {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: A (3R)-3-hydroxyacyl-[acyl-carrier protein] =
CC       a trans-2-enoyl-[acyl-carrier protein] + H(2)O.
CC       {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: An acyl-[acyl-carrier protein] + NADP(+) = a
CC       trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH.
CC       {ECO:0000269|PubMed:7567999}.
CC   -!- CATALYTIC ACTIVITY: Oleoyl-[acyl-carrier-protein] + H(2)O = [acyl-
CC       carrier-protein] + oleate. {ECO:0000269|PubMed:7567999}.
CC   -!- SUBUNIT: Homodimer which is arranged in a head to tail fashion
CC       (PubMed:17618296, PubMed:18022563, Ref.27). Interacts with
CC       CEACAM1; this interaction is insulin and phosphorylation-
CC       dependent; reduces fatty-acid synthase activity (By similarity).
CC       {ECO:0000250|UniProtKB:P12785, ECO:0000269|PubMed:17618296,
CC       ECO:0000269|PubMed:18022563, ECO:0000269|Ref.27}.
CC   -!- INTERACTION:
CC       Q99IB8:- (xeno); NbExp=6; IntAct=EBI-356658, EBI-6927928;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Prominent expression in brain,
CC       lung, and liver. {ECO:0000269|PubMed:7567999,
CC       ECO:0000269|PubMed:7595075}.
CC   -!- MISCELLANEOUS: The relatively low beta-ketoacyl synthase activity
CC       may be attributable to the low 4'-phosphopantetheine content of
CC       the protein.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB35516.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAC50259.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=BAE06070.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U26644; AAC50259.1; ALT_SEQ; mRNA.
DR   EMBL; U29344; AAA73576.1; -; mRNA.
DR   EMBL; AY451392; AAS09886.1; -; mRNA.
DR   EMBL; AB209988; BAE06070.1; ALT_INIT; mRNA.
DR   EMBL; AC135056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007267; AAH07267.1; -; mRNA.
DR   EMBL; BC007909; AAH07909.1; -; mRNA.
DR   EMBL; BC014634; AAH14634.2; -; mRNA.
DR   EMBL; BC063242; AAH63242.1; -; mRNA.
DR   EMBL; S80437; AAB35516.1; ALT_INIT; mRNA.
DR   CCDS; CCDS11801.1; -.
DR   PIR; A57788; A57788.
DR   PIR; G01880; G01880.
DR   RefSeq; NP_004095.4; NM_004104.4.
DR   RefSeq; XP_011521840.1; XM_011523538.2.
DR   UniGene; Hs.83190; -.
DR   PDB; 1XKT; X-ray; 2.60 A; A/B=2218-2502.
DR   PDB; 2CG5; X-ray; 2.70 A; B=2119-2207.
DR   PDB; 2JFD; X-ray; 2.81 A; A/B/C/D=422-823.
DR   PDB; 2JFK; X-ray; 2.40 A; A/B/C/D=422-831.
DR   PDB; 2PX6; X-ray; 2.30 A; A/B=2200-2511.
DR   PDB; 3HHD; X-ray; 2.15 A; A/B/C/D=2-963.
DR   PDB; 3TJM; X-ray; 1.48 A; A=2218-2500.
DR   PDB; 4PIV; X-ray; 2.30 A; A/B=1110-2114.
DR   PDB; 4W82; X-ray; 1.70 A; A/B=1529-1867.
DR   PDB; 4W9N; X-ray; 1.84 A; A/B/C/D=1529-1867.
DR   PDB; 4Z49; X-ray; 1.70 A; A/B=2221-2502.
DR   PDB; 5C37; X-ray; 2.30 A; A/C=1108-1523, A/C=1877-2122.
DR   PDBsum; 1XKT; -.
DR   PDBsum; 2CG5; -.
DR   PDBsum; 2JFD; -.
DR   PDBsum; 2JFK; -.
DR   PDBsum; 2PX6; -.
DR   PDBsum; 3HHD; -.
DR   PDBsum; 3TJM; -.
DR   PDBsum; 4PIV; -.
DR   PDBsum; 4W82; -.
DR   PDBsum; 4W9N; -.
DR   PDBsum; 4Z49; -.
DR   PDBsum; 5C37; -.
DR   ProteinModelPortal; P49327; -.
DR   SMR; P49327; -.
DR   BioGrid; 108488; 92.
DR   DIP; DIP-33681N; -.
DR   IntAct; P49327; 47.
DR   MINT; MINT-1146154; -.
DR   STRING; 9606.ENSP00000304592; -.
DR   BindingDB; P49327; -.
DR   ChEMBL; CHEMBL4158; -.
DR   DrugBank; DB01034; Cerulenin.
DR   DrugBank; DB01083; Orlistat.
DR   GuidetoPHARMACOLOGY; 2608; -.
DR   SwissLipids; SLP:000000765; -.
DR   ESTHER; human-FASN; Thioesterase.
DR   iPTMnet; P49327; -.
DR   PhosphoSitePlus; P49327; -.
DR   SwissPalm; P49327; -.
DR   BioMuta; FASN; -.
DR   DMDM; 269849686; -.
DR   EPD; P49327; -.
DR   MaxQB; P49327; -.
DR   PaxDb; P49327; -.
DR   PeptideAtlas; P49327; -.
DR   PRIDE; P49327; -.
DR   DNASU; 2194; -.
DR   Ensembl; ENST00000306749; ENSP00000304592; ENSG00000169710.
DR   GeneID; 2194; -.
DR   KEGG; hsa:2194; -.
DR   UCSC; uc002kdu.4; human.
DR   CTD; 2194; -.
DR   DisGeNET; 2194; -.
DR   GeneCards; FASN; -.
DR   H-InvDB; HIX0014269; -.
DR   HGNC; HGNC:3594; FASN.
DR   HPA; CAB005192; -.
DR   HPA; CAB015417; -.
DR   HPA; HPA006461; -.
DR   HPA; HPA056108; -.
DR   MIM; 600212; gene.
DR   neXtProt; NX_P49327; -.
DR   OpenTargets; ENSG00000169710; -.
DR   PharmGKB; PA28006; -.
DR   eggNOG; KOG1202; Eukaryota.
DR   eggNOG; COG3321; LUCA.
DR   GeneTree; ENSGT00530000063309; -.
DR   HOVERGEN; HBG005640; -.
DR   InParanoid; P49327; -.
DR   KO; K00665; -.
DR   OMA; VYYALHH; -.
DR   OrthoDB; EOG091G003K; -.
DR   PhylomeDB; P49327; -.
DR   TreeFam; TF300549; -.
DR   BioCyc; MetaCyc:HS09992-MONOMER; -.
DR   BRENDA; 2.3.1.85; 2681.
DR   Reactome; R-HSA-163765; ChREBP activates metabolic gene expression.
DR   Reactome; R-HSA-199220; Vitamin B5 (pantothenate) metabolism.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-75105; Fatty Acyl-CoA Biosynthesis.
DR   SABIO-RK; P49327; -.
DR   SIGNOR; P49327; -.
DR   ChiTaRS; FASN; human.
DR   EvolutionaryTrace; P49327; -.
DR   GeneWiki; Fatty_acid_synthase; -.
DR   GenomeRNAi; 2194; -.
DR   PRO; PR:P49327; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000169710; -.
DR   CleanEx; HS_FAS; -.
DR   CleanEx; HS_FASN; -.
DR   ExpressionAtlas; P49327; baseline and differential.
DR   Genevisible; P49327; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0042587; C:glycogen granule; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0047451; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004317; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; IEA:InterPro.
DR   GO; GO:0102132; F:3-oxo-pimeloyl-[acp] methyl ester reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004313; F:[acyl-carrier-protein] S-acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004314; F:[acyl-carrier-protein] S-malonyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0047117; F:enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity; IEA:UniProtKB-EC.
DR   GO; GO:0004319; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; IEA:InterPro.
DR   GO; GO:0004312; F:fatty acid synthase activity; TAS:Reactome.
DR   GO; GO:0016295; F:myristoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0070402; F:NADPH binding; IEA:Ensembl.
DR   GO; GO:0004320; F:oleoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016296; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006084; P:acetyl-CoA metabolic process; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006631; P:fatty acid metabolic process; TAS:ProtInc.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0015939; P:pantothenate metabolic process; TAS:Reactome.
DR   GO; GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome.
DR   Gene3D; 1.10.1470.20; -; 1.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR023102; Fatty_acid_synthase_dom_2.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR032821; KAsynt_C_assoc.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR013217; Methyltransf_12.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020801; PKS_acyl_transferase.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR020843; PKS_ER.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   InterPro; IPR001031; Thioesterase.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF08242; Methyltransf_12; 1.
DR   Pfam; PF00550; PP-binding; 1.
DR   Pfam; PF14765; PS-DH; 1.
DR   Pfam; PF00975; Thioesterase; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 1.
DR   SUPFAM; SSF47336; SSF47336; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 2.
DR   SUPFAM; SSF52151; SSF52151; 2.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 1.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Hydrolase; Isopeptide bond; Lipid biosynthesis;
KW   Lipid metabolism; Lyase; Multifunctional enzyme; NAD; NADP;
KW   Oxidoreductase; Phosphopantetheine; Phosphoprotein; Polymorphism;
KW   Pyridoxal phosphate; Reference proteome; Transferase; Ubl conjugation.
FT   CHAIN         1   2511       Fatty acid synthase.
FT                                /FTId=PRO_0000180276.
FT   DOMAIN     2121   2198       Carrier. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00258}.
FT   NP_BIND    1671   1688       NADP (ER). {ECO:0000250}.
FT   NP_BIND    1886   1901       NADP (KR). {ECO:0000250}.
FT   REGION        1    414       Beta-ketoacyl synthase. {ECO:0000250}.
FT   REGION      429    817       Acyl and malonyl transferases.
FT                                {ECO:0000250}.
FT   REGION     1635   1863       Enoyl reductase. {ECO:0000250}.
FT   REGION     1864   2118       Beta-ketoacyl reductase. {ECO:0000250}.
FT   REGION     2207   2511       Thioesterase. {ECO:0000250}.
FT   ACT_SITE    161    161       For beta-ketoacyl synthase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10022}.
FT   ACT_SITE    581    581       For malonyltransferase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10022}.
FT   ACT_SITE    878    878       For beta-hydroxyacyl dehydratase
FT                                activity. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10022}.
FT   ACT_SITE   2308   2308       For thioesterase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10022,
FT                                ECO:0000269|PubMed:17618296}.
FT   ACT_SITE   2481   2481       For thioesterase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10022}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES      63     63       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     207    207       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     298    298       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     436    436       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     528    528       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     673    673       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     725    725       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19096}.
FT   MOD_RES     992    992       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P19096}.
FT   MOD_RES    1174   1174       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1411   1411       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1584   1584       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1594   1594       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19096}.
FT   MOD_RES    1704   1704       N6-(pyridoxal phosphate)lysine;
FT                                alternate. {ECO:0000250}.
FT   MOD_RES    1704   1704       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1771   1771       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1847   1847       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1995   1995       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    2156   2156       O-(pantetheine 4'-phosphoryl)serine;
FT                                alternate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00258,
FT                                ECO:0000269|PubMed:7567999}.
FT   MOD_RES    2156   2156       Phosphoserine; alternate.
FT                                {ECO:0000250|UniProtKB:P12785}.
FT   MOD_RES    2198   2198       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2204   2204       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2215   2215       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2236   2236       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2391   2391       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P19096}.
FT   CROSSLNK   2449   2449       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211}.
FT   VARIANT    1483   1483       V -> I (in dbSNP:rs2228305).
FT                                /FTId=VAR_055479.
FT   VARIANT    1694   1694       R -> H (in dbSNP:rs561903908).
FT                                /FTId=VAR_055480.
FT   VARIANT    1888   1888       I -> V (in dbSNP:rs2228307).
FT                                /FTId=VAR_055481.
FT   CONFLICT    459    462       AVPA -> LSPT (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT    528    529       KP -> NR (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT    637    637       G -> A (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT    801    801       G -> R (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT    902    902       A -> P (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT    958    958       V -> M (in Ref. 3; AAS09886).
FT                                {ECO:0000305}.
FT   CONFLICT   1121   1121       P -> S (in Ref. 2; AAA73576 and 3;
FT                                AAS09886). {ECO:0000305}.
FT   CONFLICT   1151   1151       K -> T (in Ref. 6; AAH63242).
FT                                {ECO:0000305}.
FT   CONFLICT   1353   1356       LGDI -> SGH (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   1386   1386       L -> V (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   1467   1468       NR -> T (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   1827   1827       K -> E (in Ref. 3; AAS09886).
FT                                {ECO:0000305}.
FT   CONFLICT   1934   1934       R -> A (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   2065   2065       D -> H (in Ref. 9; AAB35516).
FT                                {ECO:0000305}.
FT   CONFLICT   2087   2087       R -> A (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   2363   2363       A -> P (in Ref. 9; AAB35516).
FT                                {ECO:0000305}.
FT   CONFLICT   2428   2428       R -> G (in Ref. 2; AAA73576).
FT                                {ECO:0000305}.
FT   CONFLICT   2453   2453       A -> T (in Ref. 9; AAB35516).
FT                                {ECO:0000305}.
FT   CONFLICT   2456   2456       E -> Q (in Ref. 9; AAB35516).
FT                                {ECO:0000305}.
FT   STRAND        4     13       {ECO:0000244|PDB:3HHD}.
FT   STRAND       16     18       {ECO:0000244|PDB:3HHD}.
FT   HELIX        19     27       {ECO:0000244|PDB:3HHD}.
FT   STRAND       36     40       {ECO:0000244|PDB:3HHD}.
FT   HELIX        44     46       {ECO:0000244|PDB:3HHD}.
FT   TURN         62     66       {ECO:0000244|PDB:3HHD}.
FT   HELIX        69     73       {ECO:0000244|PDB:3HHD}.
FT   HELIX        77     92       {ECO:0000244|PDB:3HHD}.
FT   HELIX        97    100       {ECO:0000244|PDB:3HHD}.
FT   STRAND      106    110       {ECO:0000244|PDB:3HHD}.
FT   HELIX       115    120       {ECO:0000244|PDB:3HHD}.
FT   TURN        124    126       {ECO:0000244|PDB:3HHD}.
FT   HELIX       130    135       {ECO:0000244|PDB:3HHD}.
FT   HELIX       139    148       {ECO:0000244|PDB:3HHD}.
FT   STRAND      154    158       {ECO:0000244|PDB:3HHD}.
FT   HELIX       160    162       {ECO:0000244|PDB:3HHD}.
FT   HELIX       163    176       {ECO:0000244|PDB:3HHD}.
FT   STRAND      181    189       {ECO:0000244|PDB:3HHD}.
FT   HELIX       194    202       {ECO:0000244|PDB:3HHD}.
FT   STRAND      227    235       {ECO:0000244|PDB:3HHD}.
FT   HELIX       236    238       {ECO:0000244|PDB:3HHD}.
FT   STRAND      243    253       {ECO:0000244|PDB:3HHD}.
FT   HELIX       266    279       {ECO:0000244|PDB:3HHD}.
FT   HELIX       284    286       {ECO:0000244|PDB:3HHD}.
FT   STRAND      287    291       {ECO:0000244|PDB:3HHD}.
FT   HELIX       300    312       {ECO:0000244|PDB:3HHD}.
FT   STRAND      320    323       {ECO:0000244|PDB:3HHD}.
FT   HELIX       326    329       {ECO:0000244|PDB:3HHD}.
FT   HELIX       333    335       {ECO:0000244|PDB:3HHD}.
FT   HELIX       336    350       {ECO:0000244|PDB:3HHD}.
FT   HELIX       367    370       {ECO:0000244|PDB:3HHD}.
FT   STRAND      373    376       {ECO:0000244|PDB:3HHD}.
FT   STRAND      387    393       {ECO:0000244|PDB:3HHD}.
FT   STRAND      397    406       {ECO:0000244|PDB:3HHD}.
FT   HELIX       416    419       {ECO:0000244|PDB:3HHD}.
FT   STRAND      422    430       {ECO:0000244|PDB:3HHD}.
FT   HELIX       431    443       {ECO:0000244|PDB:3HHD}.
FT   TURN        444    446       {ECO:0000244|PDB:3HHD}.
FT   HELIX       448    457       {ECO:0000244|PDB:3HHD}.
FT   TURN        462    464       {ECO:0000244|PDB:3HHD}.
FT   STRAND      467    477       {ECO:0000244|PDB:3HHD}.
FT   STRAND      481    484       {ECO:0000244|PDB:3HHD}.
FT   STRAND      492    496       {ECO:0000244|PDB:3HHD}.
FT   TURN        504    509       {ECO:0000244|PDB:3HHD}.
FT   HELIX       510    512       {ECO:0000244|PDB:3HHD}.
FT   HELIX       514    527       {ECO:0000244|PDB:3HHD}.
FT   HELIX       528    530       {ECO:0000244|PDB:3HHD}.
FT   HELIX       534    539       {ECO:0000244|PDB:3HHD}.
FT   HELIX       545    547       {ECO:0000244|PDB:3HHD}.
FT   HELIX       549    569       {ECO:0000244|PDB:3HHD}.
FT   STRAND      575    579       {ECO:0000244|PDB:3HHD}.
FT   HELIX       583    590       {ECO:0000244|PDB:3HHD}.
FT   HELIX       596    611       {ECO:0000244|PDB:3HHD}.
FT   STRAND      618    625       {ECO:0000244|PDB:3HHD}.
FT   HELIX       627    633       {ECO:0000244|PDB:3HHD}.
FT   STRAND      639    645       {ECO:0000244|PDB:3HHD}.
FT   STRAND      648    654       {ECO:0000244|PDB:3HHD}.
FT   HELIX       655    667       {ECO:0000244|PDB:3HHD}.
FT   STRAND      672    675       {ECO:0000244|PDB:3HHD}.
FT   STRAND      677    679       {ECO:0000244|PDB:2JFD}.
FT   HELIX       685    690       {ECO:0000244|PDB:3HHD}.
FT   HELIX       691    701       {ECO:0000244|PDB:3HHD}.
FT   STRAND      702    704       {ECO:0000244|PDB:2JFD}.
FT   STRAND      715    717       {ECO:0000244|PDB:3HHD}.
FT   HELIX       719    721       {ECO:0000244|PDB:3HHD}.
FT   HELIX       725    728       {ECO:0000244|PDB:3HHD}.
FT   HELIX       732    740       {ECO:0000244|PDB:3HHD}.
FT   HELIX       745    749       {ECO:0000244|PDB:3HHD}.
FT   STRAND      757    764       {ECO:0000244|PDB:3HHD}.
FT   HELIX       768    774       {ECO:0000244|PDB:3HHD}.
FT   STRAND      780    783       {ECO:0000244|PDB:3HHD}.
FT   HELIX       792    805       {ECO:0000244|PDB:3HHD}.
FT   HELIX       812    815       {ECO:0000244|PDB:3HHD}.
FT   HELIX       831    833       {ECO:0000244|PDB:3HHD}.
FT   HELIX       847    849       {ECO:0000244|PDB:3HHD}.
FT   STRAND     1113   1127       {ECO:0000244|PDB:4PIV}.
FT   TURN       1128   1130       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1132   1149       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1173   1175       {ECO:0000244|PDB:5C37}.
FT   HELIX      1177   1187       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1200   1205       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1206   1211       {ECO:0000244|PDB:4PIV}.
FT   TURN       1213   1220       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1222   1233       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1236   1245       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1247   1250       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1252   1254       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1256   1260       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1263   1265       {ECO:0000244|PDB:5C37}.
FT   STRAND     1267   1275       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1277   1283       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1284   1289       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1293   1296       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1305   1307       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1309   1316       {ECO:0000244|PDB:4PIV}.
FT   TURN       1317   1319       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1325   1335       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1336   1349       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1352   1360       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1374   1383       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1387   1394       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1397   1404       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1413   1416       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1424   1433       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1441   1445       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1453   1460       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1466   1468       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1469   1474       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1491   1499       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1502   1507       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1510   1518       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1531   1537       {ECO:0000244|PDB:4W82}.
FT   HELIX      1541   1543       {ECO:0000244|PDB:4W82}.
FT   STRAND     1544   1548       {ECO:0000244|PDB:4W82}.
FT   STRAND     1562   1570       {ECO:0000244|PDB:4W82}.
FT   HELIX      1573   1579       {ECO:0000244|PDB:4W82}.
FT   HELIX      1585   1587       {ECO:0000244|PDB:4W82}.
FT   HELIX      1589   1592       {ECO:0000244|PDB:4W82}.
FT   STRAND     1602   1606       {ECO:0000244|PDB:4W82}.
FT   STRAND     1612   1616       {ECO:0000244|PDB:4W82}.
FT   STRAND     1622   1628       {ECO:0000244|PDB:4W82}.
FT   HELIX      1630   1632       {ECO:0000244|PDB:4W82}.
FT   STRAND     1633   1635       {ECO:0000244|PDB:4W82}.
FT   HELIX      1642   1645       {ECO:0000244|PDB:4W82}.
FT   HELIX      1649   1659       {ECO:0000244|PDB:4W82}.
FT   TURN       1660   1663       {ECO:0000244|PDB:4W82}.
FT   STRAND     1670   1675       {ECO:0000244|PDB:4W82}.
FT   HELIX      1679   1690       {ECO:0000244|PDB:4W82}.
FT   STRAND     1694   1701       {ECO:0000244|PDB:4W82}.
FT   HELIX      1702   1711       {ECO:0000244|PDB:4W82}.
FT   HELIX      1717   1719       {ECO:0000244|PDB:4W82}.
FT   STRAND     1720   1722       {ECO:0000244|PDB:4W82}.
FT   STRAND     1723   1726       {ECO:0000244|PDB:4W9N}.
FT   HELIX      1728   1735       {ECO:0000244|PDB:4W82}.
FT   TURN       1736   1738       {ECO:0000244|PDB:4W82}.
FT   STRAND     1741   1746       {ECO:0000244|PDB:4W82}.
FT   TURN       1747   1751       {ECO:0000244|PDB:4W9N}.
FT   HELIX      1753   1757       {ECO:0000244|PDB:4W82}.
FT   STRAND     1760   1769       {ECO:0000244|PDB:4W82}.
FT   TURN       1784   1788       {ECO:0000244|PDB:4W82}.
FT   STRAND     1790   1794       {ECO:0000244|PDB:4W82}.
FT   HELIX      1796   1799       {ECO:0000244|PDB:4W82}.
FT   TURN       1801   1803       {ECO:0000244|PDB:4W9N}.
FT   HELIX      1805   1819       {ECO:0000244|PDB:4W82}.
FT   STRAND     1828   1832       {ECO:0000244|PDB:4W82}.
FT   HELIX      1833   1835       {ECO:0000244|PDB:4W82}.
FT   HELIX      1836   1845       {ECO:0000244|PDB:4W82}.
FT   STRAND     1849   1857       {ECO:0000244|PDB:4W82}.
FT   STRAND     1885   1890       {ECO:0000244|PDB:4PIV}.
FT   TURN       1891   1893       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1895   1906       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1911   1915       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1923   1934       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1938   1942       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1949   1962       {ECO:0000244|PDB:4PIV}.
FT   STRAND     1965   1970       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1980   1982       {ECO:0000244|PDB:4PIV}.
FT   HELIX      1985   2009       {ECO:0000244|PDB:4PIV}.
FT   STRAND     2015   2021       {ECO:0000244|PDB:4PIV}.
FT   HELIX      2022   2025       {ECO:0000244|PDB:4PIV}.
FT   HELIX      2032   2050       {ECO:0000244|PDB:4PIV}.
FT   STRAND     2056   2060       {ECO:0000244|PDB:4PIV}.
FT   STRAND     2065   2067       {ECO:0000244|PDB:4PIV}.
FT   TURN       2068   2070       {ECO:0000244|PDB:4PIV}.
FT   STRAND     2075   2077       {ECO:0000244|PDB:5C37}.
FT   HELIX      2088   2099       {ECO:0000244|PDB:4PIV}.
FT   STRAND     2104   2111       {ECO:0000244|PDB:4PIV}.
FT   HELIX      2127   2134       {ECO:0000244|PDB:2CG5}.
FT   TURN       2149   2153       {ECO:0000244|PDB:2CG5}.
FT   HELIX      2156   2170       {ECO:0000244|PDB:2CG5}.
FT   HELIX      2176   2180       {ECO:0000244|PDB:2CG5}.
FT   HELIX      2184   2192       {ECO:0000244|PDB:2CG5}.
FT   HELIX      2219   2222       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2230   2233       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2239   2241       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2244   2247       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2255   2257       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2258   2263       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2268   2271       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2282   2293       {ECO:0000244|PDB:3TJM}.
FT   TURN       2294   2296       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2303   2307       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2309   2325       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2333   2338       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2343   2352       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2360   2375       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2380   2387       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2390   2392       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2393   2407       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2413   2432       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2443   2447       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2453   2458       {ECO:0000244|PDB:4Z49}.
FT   TURN       2459   2463       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2464   2466       {ECO:0000244|PDB:3TJM}.
FT   STRAND     2472   2476       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2483   2485       {ECO:0000244|PDB:3TJM}.
FT   HELIX      2487   2499       {ECO:0000244|PDB:3TJM}.
SQ   SEQUENCE   2511 AA;  273427 MW;  7A07171FEFA3287B CRC64;
     MEEVVIAGMS GKLPESENLQ EFWDNLIGGV DMVTDDDRRW KAGLYGLPRR SGKLKDLSRF
     DASFFGVHPK QAHTMDPQLR LLLEVTYEAI VDGGINPDSL RGTHTGVWVG VSGSETSEAL
     SRDPETLVGY SMVGCQRAMM ANRLSFFFDF RGPSIALDTA CSSSLMALQN AYQAIHSGQC
     PAAIVGGINV LLKPNTSVQF LRLGMLSPEG TCKAFDTAGN GYCRSEGVVA VLLTKKSLAR
     RVYATILNAG TNTDGFKEQG VTFPSGDIQE QLIRSLYQSA GVAPESFEYI EAHGTGTKVG
     DPQELNGITR ALCATRQEPL LIGSTKSNMG HPEPASGLAA LAKVLLSLEH GLWAPNLHFH
     SPNPEIPALL DGRLQVVDQP LPVRGGNVGI NSFGFGGSNV HIILRPNTQP PPAPAPHATL
     PRLLRASGRT PEAVQKLLEQ GLRHSQDLAF LSMLNDIAAV PATAMPFRGY AVLGGERGGP
     EVQQVPAGER PLWFICSGMG TQWRGMGLSL MRLDRFRDSI LRSDEAVKPF GLKVSQLLLS
     TDESTFDDIV HSFVSLTAIQ IGLIDLLSCM GLRPDGIVGH SLGEVACGYA DGCLSQEEAV
     LAAYWRGQCI KEAHLPPGAM AAVGLSWEEC KQRCPPGVVP ACHNSKDTVT ISGPQAPVFE
     FVEQLRKEGV FAKEVRTGGM AFHSYFMEAI APPLLQELKK VIREPKPRSA RWLSTSIPEA
     QWHSSLARTS SAEYNVNNLV SPVLFQEALW HVPEHAVVLE IAPHALLQAV LKRGLKPSCT
     IIPLMKKDHR DNLEFFLAGI GRLHLSGIDA NPNALFPPVE FPAPRGTPLI SPLIKWDHSL
     AWDVPAAEDF PNGSGSPSAA IYNIDTSSES PDHYLVDHTL DGRVLFPATG YLSIVWKTLA
     RALGLGVEQL PVVFEDVVLH QATILPKTGT VSLEVRLLEA SRAFEVSENG NLVVSGKVYQ
     WDDPDPRLFD HPESPTPNPT EPLFLAQAEV YKELRLRGYD YGPHFQGILE ASLEGDSGRL
     LWKDNWVSFM DTMLQMSILG SAKHGLYLPT RVTAIHIDPA THRQKLYTLQ DKAQVADVVV
     SRWLRVTVAG GVHISGLHTE SAPRRQQEQQ VPILEKFCFT PHTEEGCLSE RAALQEELQL
     CKGLVQALQT KVTQQGLKMV VPGLDGAQIP RDPSQQELPR LLSAACRLQL NGNLQLELAQ
     VLAQERPKLP EDPLLSGLLD SPALKACLDT AVENMPSLKM KVVEVLAGHG HLYSRIPGLL
     SPHPLLQLSY TATDRHPQAL EAAQAELQQH DVAQGQWDPA DPAPSALGSA DLLVCNCAVA
     ALGDPASALS NMVAALREGG FLLLHTLLRG HPLGDIVAFL TSTEPQYGQG ILSQDAWESL
     FSRVSLRLVG LKKSFYGSTL FLCRRPTPQD SPIFLPVDDT SFRWVESLKG ILADEDSSRP
     VWLKAINCAT SGVVGLVNCL RREPGGNRLR CVLLSNLSST SHVPEVDPGS AELQKVLQGD
     LVMNVYRDGA WGAFRHFLLE EDKPEEPTAH AFVSTLTRGD LSSIRWVCSS LRHAQPTCPG
     AQLCTVYYAS LNFRDIMLAT GKLSPDAIPG KWTSQDSLLG MEFSGRDASG KRVMGLVPAK
     GLATSVLLSP DFLWDVPSNW TLEEAASVPV VYSTAYYALV VRGRVRPGET LLIHSGSGGV
     GQAAIAIALS LGCRVFTTVG SAEKRAYLQA RFPQLDSTSF ANSRDTSFEQ HVLWHTGGKG
     VDLVLNSLAE EKLQASVRCL ATHGRFLEIG KFDLSQNHPL GMAIFLKNVT FHGVLLDAFF
     NESSADWREV WALVQAGIRD GVVRPLKCTV FHGAQVEDAF RYMAQGKHIG KVVVQVLAEE
     PEAVLKGAKP KLMSAISKTF CPAHKSYIIA GGLGGFGLEL AQWLIQRGVQ KLVLTSRSGI
     RTGYQAKQVR RWRRQGVQVQ VSTSNISSLE GARGLIAEAA QLGPVGGVFN LAVVLRDGLL
     ENQTPEFFQD VCKPKYSGTL NLDRVTREAC PELDYFVVFS SVSCGRGNAG QSNYGFANSA
     MERICEKRRH EGLPGLAVQW GAIGDVGILV ETMSTNDTIV SGTLPQRMAS CLEVLDLFLN
     QPHMVLSSFV LAEKAAAYRD RDSQRDLVEA VAHILGIRDL AAVNLDSSLA DLGLDSLMSV
     EVRQTLEREL NLVLSVREVR QLTLRKLQEL SSKADEASEL ACPTPKEDGL AQQQTQLNLR
     SLLVNPEGPT LMRLNSVQSS ERPLFLVHPI EGSTTVFHSL ASRLSIPTYG LQCTRAAPLD
     SIHSLAAYYI DCIRQVQPEG PYRVAGYSYG ACVAFEMCSQ LQAQQSPAPT HNSLFLFDGS
     PTYVLAYTQS YRAKLTPGCE AEAETEAICF FVQQFTDMEH NRVLEALLPL KGLEERVAAA
     VDLIIKSHQG LDRQELSFAA RSFYYKLRAA EQYTPKAKYH GNVMLLRAKT GGAYGEDLGA
     DYNLSQVCDG KVSVHVIEGD HRTLLEGSGL ESIISIIHSS LAEPRVSVRE G
//
